Eloxatin (Oxaliplatin)
Showing 1 - 25 of 1,508
Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)
Recruiting
- Colonic Neoplasms
- +2 more
- Tislelizumab
- +3 more
-
Nanning, Guangxi, ChinaThe First Affiliated Hospital of Guangxi Medical University
Nov 9, 2023
Malignant Digestive System Tumor Trial in Atlanta (Fluorouracil, Leucovorin, Oxaliplatin)
Recruiting
- Malignant Digestive System Neoplasm
- Fluorouracil
- +2 more
-
Atlanta, Georgia
- +2 more
Dec 12, 2022
GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)
Recruiting
- GastroEsophageal Cancer
- Gastric Cancer
- Neratinib
- +4 more
-
Tampa, FloridaMoffitt Cancer Center
Oct 25, 2023
GastroEsophageal Cancer Trial in Boston (Irinotecan, Oxaliplatin, Leucovorin)
Active, not recruiting
- GastroEsophageal Cancer
- Irinotecan
- +6 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 7, 2022
Pancreatic Cancer Trial in Sydney, Wollongong, Melbourne (Durvalumab, Oxaliplatin, Irinotecan)
Recruiting
- Pancreatic Cancer
- Durvalumab
- +5 more
-
Sydney, New South Wales, Australia
- +2 more
Oct 19, 2023
Locally Advanced Unresectable or Metastatic Esophageal Cancer Trial (Futibatinib, Pembrolizumab, Cisplatin)
Not yet recruiting
- Locally Advanced Unresectable or Metastatic Esophageal Cancer
- Futibatinib
- +6 more
- (no location specified)
Jul 6, 2023
Colorectal Tumors Trial in Philadelphia (bevacizumab, cetuximab, Oxaliplatin)
Terminated
- Colorectal Neoplasms
- bevacizumab
- +3 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 30, 2021
Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With
Enrolling by invitation
- Gastric Cancer
- Gastrectomy
- +3 more
-
Shanghai, Shanghai, ChinaZhongshan hospital
May 1, 2022
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 19, 2022
Pancreas Cancer, Adenocarcinoma of the Pancreas Trial in Omaha (Digoxin, 5Fluorouracil, Calcium Leucovorin)
Recruiting
- Pancreas Cancer
- Adenocarcinoma of the Pancreas
- Digoxin
- +4 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Mar 31, 2022
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma, Refractory Colorectal Carcinoma Trial in Livingston, New Brunswick
Recruiting
- Metastatic Colorectal Carcinoma
- +5 more
- Oxaliplatin
- Trifluridine and Tipiracil Hydrochloride
-
Elizabeth, New Jersey
- +5 more
Oct 17, 2022
Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,
Not yet recruiting
- Pancreatic Cancer
- +3 more
- mFOLFIRINOX
- +7 more
-
Boston, Massachusetts
- +1 more
Sep 16, 2022
Locally Advanced Rectal Cancer Trial in Miami (Intensity-modulated radiation therapy, 5-fluorouracil, Leucovorin)
Recruiting
- Locally Advanced Rectal Cancer
- Intensity-modulated radiation therapy
- +5 more
-
Miami, FloridaUniversity of Miami
Oct 28, 2022
Carcinoma Trial in Saint Louis (Intraperitoneal Oxaliplatin, Bevacizumab, Capecitabine)
Active, not recruiting
- Carcinoma
- Intraperitoneal Oxaliplatin
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Nov 8, 2021
Cholangiocarcinoma, Liver Tumors Trial in Saint Louis (Floxuridine, Dexamethasone, Gemcitabine)
Terminated
- Cholangiocarcinoma
- Liver Neoplasms
- Floxuridine
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 8, 2022
Colorectal Adenocarcinoma, Oesogastric Trial in France (Trifluridine/Tipiracil, Oxaliplatin)
Recruiting
- Colorectal Adenocarcinoma
- Oesogastric
-
Besançon, France
- +10 more
Jan 28, 2022
Recurrent NSCLC Trial in Changchun, Shanghai (Cisplatin, Carboplatin, Docetaxel)
Recruiting
- Recurrent Non-small Cell Lung Cancer
- Cisplatin
- +7 more
-
Changchun, Jilin, China
- +2 more
May 3, 2022
Pancreatic Cancer Trial in Cleveland (CPI 613, Oxaliplatin, Irinotecan)
Active, not recruiting
- Pancreatic Cancer
- CPI 613
- +4 more
-
Cleveland, OhioUniversity Hospitals Cleveland Medical Center, Case Comprehensiv
Sep 14, 2022
Rectal Tumors Trial in Guangzhou (Oxaliplatin, capecitabine, Radiation)
Active, not recruiting
- Rectal Neoplasms
- Oxaliplatin
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University, Cancer Center
Jul 26, 2022
Breast Cancer Trial in United States (Trastuzumab, Oxaliplatin)
Completed
- Breast Cancer
-
Bowling Green, Kentucky
- +6 more
Oct 13, 2021